Akero Therapeutics, Inc. (AKRO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.87B |
| Enterprise Value | 1.56B |
| P/E Ratio | -14.61 |
| PEG Ratio | -65.07 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.68 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -15 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.29 |
| Return On Equity | -0.31 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -247.37M |
| Net Income | -252.06M |
| Diluted EPS | -3.75 |
| Total Cash | 737.83M |
| Total Cash/Share | 9 |
| Total Debt | 1.16M |
| Total Debt/Equity | 0 |
| Current Ratio | 15.83 |
| Book Value Per Share | 11.68 |
| 52-Week Change | 108.91 |
| 52-Week High | 58.4 |
| 52-Week Low | 21.34 |
| Moving Average 50 Days | 53.06 |
| Moving Average 200 Days | 48.19 |
| Average Volume | 2.56M |
| Shares Outstanding | 82.32M |
| % Held by Institutions | 111.91 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |